Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell …
M Nyakern, A Cappellini, I Mantovani… - Molecular Cancer …, 2006 - AACR
Perifosine is an Akt inhibitor displaying strong antineoplastic effects in human tumor cell
lines and is currently being tested in phase II clinical trials for treatment of major human …
lines and is currently being tested in phase II clinical trials for treatment of major human …
[引用][C] Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated …
M Nyakern, A Cappellini, I Mantovani… - MOLECULAR CANCER …, 2006 - cris.unibo.it
Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and
etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways IRIS …
etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways IRIS …
Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell …
M Nyåkern, A Cappellini… - Molecular cancer …, 2006 - pubmed.ncbi.nlm.nih.gov
Perifosine is an Akt inhibitor displaying strong antineoplastic effects in human tumor cell
lines and is currently being tested in phase II clinical trials for treatment of major human …
lines and is currently being tested in phase II clinical trials for treatment of major human …
Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell …
M Nyåkern, A Cappellini, I Mantovani… - Molecular Cancer …, 2006 - europepmc.org
Perifosine is an Akt inhibitor displaying strong antineoplastic effects in human tumor cell
lines and is currently being tested in phase II clinical trials for treatment of major human …
lines and is currently being tested in phase II clinical trials for treatment of major human …
[PDF][PDF] Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated …
M Nyakern, A Cappellini, I Mantovani, AM Martelli - Mol Cancer Ther, 2006 - academia.edu
Perifosine is an Akt inhibitor displaying strong antineoplastic effects in human tumor cell
lines and is currently being tested in phase II clinical trials for treatment of major human …
lines and is currently being tested in phase II clinical trials for treatment of major human …
[PDF][PDF] Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated …
M Nyakern, A Cappellini, I Mantovani, AM Martelli - Mol Cancer Ther, 2006 - iris.unicas.it
Perifosine is an Akt inhibitor displaying strong antineoplastic effects in human tumor cell
lines and is currently being tested in phase II clinical trials for treatment of major human …
lines and is currently being tested in phase II clinical trials for treatment of major human …
[PDF][PDF] Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated …
M Nyakern, A Cappellini, I Mantovani, AM Martelli - Mol Cancer Ther, 2006 - iris.unicas.it
Perifosine is an Akt inhibitor displaying strong antineoplastic effects in human tumor cell
lines and is currently being tested in phase II clinical trials for treatment of major human …
lines and is currently being tested in phase II clinical trials for treatment of major human …